ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $26.4M invested in ESSA Pharma in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$13M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$7.61M |
| 3 |
AIC
AWM Investment Company
New York
|
+$5.08M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.01M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.59M |
Top Sellers
EPIX Hedge Fund Activity: Q3 2015 in Review
10 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q3 2015, worth a combined $26.4M.
Buyers outnumbered sellers: 10 funds opened new EPIX positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $13M.
- 10 institutional investors held ESSA Pharma (EPIX) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $26.4M of ESSA Pharma stock for Q3 2015.
- 10 funds opened new ESSA Pharma positions in Q3 2015 and 0 closed out, a net change of +10 holders.
- The largest ESSA Pharma buyer in Q3 2015 was Deerfield Management, an estimated $13M added.
Based on aggregated 13F filings for Q3 2015.